Skip to main content

Table 2 Baseline characteristics of study infants at delivery (%)

From: Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

 

AL

ASAQ

MQAS

DHAPQ

p-valuea

N

Value

N

Value

N

Value

N

Value

Live births by country

0.85

 Burkina Faso

280

278 (99.3)

279

278 (99.6)

275

268 (97.5)

   

 Ghana

  

245

235 (95.9)

241

229 (95.0)

252

243 (96.4)

 

 Malawi

276

269 (97.5)

269

262 (97.4)

  

270

268 (99.3)

 

 Zambia

282

275 (97.5)

  

273

268 (98.2)

264

254 (96.2)

 

 Birth asphyxia

706

19 (2.7)

635

42 (6.6)

658

44 (6.7)

648

39 (6.0)

0.91

 Congenital abnormalityb

815

17 (2.1)

757

12 (1.6)

751

12 (1.6)

742

6 (0.8)

0.35

 Prematurityc

838

78 (9.3)

793

25 (3.2)

789

57 (7.2)

786

70 (8.9)

0.65

 Congenital malariad

808

7 (0.9)

727

2 (0.3)

719

1 (0.1)

711

1 (0.1)

0.15

 Anaemia at birthd

793

12 (1.5)

720

7 (1.0)

713

10 (1.4)

696

10 (1.4)

0.36

 Birth weight mean (SD)

804

2856 (452)

742

2873 (463)

733

2860 (460)

720

2889 (463)

0.56

 LBW < 2500 g

804

138 (17.2)

742

118 (15.9)

733

119 (16.2)

720

105 (14.6)

0.54

  1. aAdjusted by country
  2. bReported as SAE at delivery
  3. cCalculated by Ballard score
  4. dCord blood at 14 g/dL cut off for congenital anaemia and cord blood for malaria